Divalproex and its effect on suicide risk in bipolar disorder: A systematic review and meta-analysis of multinational observational studies

Journal of Affective Disorders

Volumn 245, Issue , 2019, Pages 812-818

  Chen, Tien Yu ^a,b   Kamali, Masoud ^c   Chu, Che Sheng ^d   Yeh, Chin Bin ^a   Huang, San Yuan ^a   Mao, Wei Chung ^b,e   Lin, Pao Yen ^f,g   Chen, Yen Wen ^h   Tseng, Ping Tao ⁱ   Hsu, Chung Yao ^j  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^f CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^g CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^h Prospect clinic for otorhinolaryngology and neurology   (Taiwan)

ⁱ Winshine clinics in specialty of psychiatry   (Taiwan)

^j KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

more..

Author keywords

Divalproex; Meta analysis; Pharmacotherapy; Suicidality

Indexed keywords

CARBAMAZEPINE; VALPROATE SEMISODIUM; TRANQUILIZER; VALPROIC ACID;

ARTICLE; BIPOLAR DISORDER; CLINICAL OUTCOME; DRUG EFFECT; FOLLOW UP; HUMAN; INCIDENCE; MENTAL PATIENT; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SUICIDE; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; INTERNATIONAL COOPERATION; STATISTICS AND NUMERICAL DATA;

ANTIMANIC AGENTS; BIPOLAR DISORDER; HUMANS; INTERNATIONALITY; OBSERVATIONAL STUDIES AS TOPIC; SUICIDE; SUICIDE, ATTEMPTED; VALPROIC ACID;

EID: 85056648863     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2018.11.093     Document Type: Article

References (51)

1. US FD Administration. Suicidal behavior and ideation and antiepileptic drugs. (update) https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm100190.htm, 2009.
2. Ahearn, E.P., Chen, P., Hertzberg, M., Cornette, M., Suvalsky, L., Cooley-Olson, D., Swanlund, J., Eickhoff, J., Becker, T., Krahn, D., Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics. J. Affect. Disord. 145 (2013), 77–82.
3. Arana, A., Wentworth, C.E., Ayuso-Mateos, J.L., Arellano, F.M., Suicide-related events in patients treated with antiepileptic drugs. N. Engl. J. Med. 363 (2010), 542–551.
4. Balazs, J., Benazzi, F., Rihmer, Z., Rihmer, A., Akiskal, K.K., Akiskal, H.S., The close link between suicide attempts and mixed (bipolar) depression: implications for suicide prevention. J. Affect. Disord. 91 (2006), 133–138.
5. Baldessarini, R., Henk, H., Sklar, A., Chang, J., Leahy, L., Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr. Serv. 59 (2008), 1175–1183.
6. Bellivier, F., Belzeaux, R., Scott, J., Courtet, P., Golmard, J.L., Azorin, J.M., Anticonvulsants and suicide attempts in bipolar I disorders. Acta Psychiatr. Scand. 135 (2017), 470–478.
7. Blanco, C., Laje, G., Olfson, M., Marcus, S.C., Pincus, H.A., Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am. J. Psychiatry 159 (2002), 1005–1010.
8. Bond, D.J., Lam, R.W., Yatham, L.N., Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis. J. Affect. Disord. 124 (2010), 228–234.
9. Borenstein, M., Hedges, L.V., Higgins, J.P., Rothstein, H.R., A basic introduction to fixed-effect and random-effects models for meta-analysis. Res. Synth. Methods 1 (2010), 97–111.
10. Borenstein, M., Higgins, J.P., Hedges, L.V., Rothstein, H.R., Basics of meta-analysis: I2 is not an absolute measure of heterogeneity. Res. Synth. Methods 8 (2017), 5–18.
11. Cipriani, A., Hawton, K., Stockton, S., Geddes, J.R., Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ, 346, 2013, f3646.
12. Collins, J.C., McFarland, B.H., Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. J. Affect. Disord. 107 (2008), 23–28.
13. Davey, J., Turner, R.M., Clarke, M.J., Higgins, J.P., Characteristics of meta-analyses and their component studies in the Cochrane database of systematic reviews: a cross-sectional, descriptive analysis. BMC Med. Res. Methodol., 11, 2011, 160.
14. de Toffol, B., Comment on anticonvulsants and suicide attempts in bipolar type I disorders. Acta Psychiatr. Scand., 136, 2017, 141.
15. Deady, M., Choi, I., Calvo, R.A., Glozier, N., Christensen, H., Harvey, S.B., eHealth interventions for the prevention of depression and anxiety in the general population: a systematic review and meta-analysis. BMC Psychiatry, 17, 2017, 310.
16. Downs, S.H., Black, N., The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J. Epidemiol. Community Health 52 (1998), 377–384.
17. Duval, S., Tweedie, R., Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56 (2000), 455–463.
18. Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
19. El-Mallakh, R.S., Salem, M.R., Chopra, A., Mickus, G.J., Penagaluri, P., Movva, R., A blinded, randomized comparison of immediate-release and extended-release carbamazepine capsules in manic and depressed bipolar subjects. Ann. Clin. Psychiatry 22 (2010), 3–8.
20. National Institute for Health and Care Excellence. Bipolar disorder: the assessment and management of bipolar disorder in adults, children and young people in primary and secondary care. (Clinical Guideline 185) https://www.nice.org.uk/guidance/CG185, 2014.
21. Ferrari, A.J., Baxter, A.J., Whiteford, H.A., A systematic review of the global distribution and availability of prevalence data for bipolar disorder. J. Affect. Disord. 134 (2011), 1–13.
22. Ferrari, A.J., Stockings, E., Khoo, J.P., Erskine, H.E., Degenhardt, L., Vos, T., Whiteford, H.A., The prevalence and burden of bipolar disorder: findings from the global burden of disease study 2013. Bipolar Disord. 18 (2016), 440–450.
23. Gibbons, R.D., Hur, K., Brown, C.H., Mann, J.J., Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch. Gen. Psychiatry 66 (2009), 1354–1360.
24. Goodwin, F.K., Fireman, B., Simon, G.E., Hunkeler, E.M., Lee, J., Revicki, D., Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 290 (2003), 1467–1473.
25. Goodwin, G.M., Haddad, P.M., Ferrier, I.N., Aronson, J.K., Barnes, T., Cipriani, A., Coghill, D.R., Fazel, S., Geddes, J.R., Grunze, H., Holmes, E.A., Howes, O., Hudson, S., Hunt, N., Jones, I., Macmillan, I.C., McAllister-Williams, H., Miklowitz, D.R., Morriss, R., Munafo, M., Paton, C., Saharkian, B.J., Saunders, K., Sinclair, J., Taylor, D., Vieta, E., Young, A.H., Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 30 (2016), 495–553.
26. Hayes, J.F., Miles, J., Walters, K., King, M., Osborn, D.P., A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr. Scand. 131 (2015), 417–425.
27. Hayes, J.F., Pitman, A., Marston, L., Walters, K., Geddes, J.R., King, M., Osborn, D.P., Self-harm, unintentional injury, and suicide in bipolar disorder during maintenance mood stabilizer treatment: a UK population-based electronic health records study. JAMA Psychiatry 73 (2016), 630–637.
28. Higgins, J.P., Green, S., 10.4.3.1 recommendations on testing for funnel plot asymmetry. Higgins, J.P., Green, S., (eds.) Cochrane Handbook for Systematic Reviews of Interventions, 5.1.0 ed., 2011, Cochrane Library.
29. Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
30. Huband, N., Ferriter, M., Nathan, R., Jones, H., Antiepileptics for aggression and associated impulsivity. Cochrane Database Syst. Rev., 2010, CD003499, 10.1002/14651858.CD003499.pub3.
31. Jeong, J.H., Lee, J.G., Kim, M.D., Sohn, I., Shim, S.H., Wang, H.R., Woo, Y.S., Jon, D.I., Seo, J.S., Shin, Y.C., Min, K.J., Yoon, B.H., Bahk, W.M., Korean medication algorithm for bipolar disorder 2014: comparisons with other treatment guidelines. Neuropsychiatr. Dis. Treat. 11 (2015), 1561–1571.
32. Kanba, S., Kato, T., Terao, T., Yamada, K., Committee for Treatment Guidelines of Mood Disorders, J.S.o.M.D. Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012. Psychiatry Clin. Neurosci. 67 (2013), 285–300.
33. Leon, A.C., Solomon, D.A., Li, C., Fiedorowicz, J.G., Coryell, W.H., Endicott, J., Keller, M.B., Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational study. Am. J. Psychiatry 169 (2012), 285–291.
34. Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gotzsche, P.C., Ioannidis, J.P., Clarke, M., Devereaux, P.J., Kleijnen, J., Moher, D., The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med., 6, 2009, e1000100.
35. McKnight, R.F., Adida, M., Budge, K., Stockton, S., Goodwin, G.M., Geddes, J.R., Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379 (2012), 721–728.
36. Olesen, J.B., Hansen, P.R., Erdal, J., Abildstrom, S.Z., Weeke, P., Fosbol, E.L., Poulsen, H.E., Gislason, G.H., Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol. Drug Saf. 19 (2010), 518–524.
37. Patorno, E., Bohn, R.L., Wahl, P.M., Avorn, J., Patrick, A.R., Liu, J., Schneeweiss, S., Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA 303 (2010), 1401–1409.
38. Pugh, M.J., Copeland, L.A., Zeber, J.E., Wang, C.P., Amuan, M.E., Mortensen, E.M., Tabares, J.V., Van Cott, A.C., Cooper, T.L., Cramer, J.A., Antiepileptic drug monotherapy exposure and suicide-related behavior in older veterans. J. Am. Geriatr. Soc. 60 (2012), 2042–2047.
39. Redden, L., Pritchett, Y., Robieson, W., Kovacs, X., Garofalo, M., Tracy, K., Saltarelli, M., Suicidality and divalproex sodium: analysis of controlled studies in multiple indications. Ann. Gen. Psychiatry, 10, 2011, 1.
40. Samoocha, D., Bruinvels, D.J., Elbers, N.A., Anema, J.R., van der Beek, A.J., Effectiveness of web-based interventions on patient empowerment: a systematic review and meta-analysis. J. Med. Internet Res., 12, 2010, e23.
41. Sanchez-Gistau, V., Colom, F., Mane, A., Romero, S., Sugranyes, G., Vieta, E., Atypical depression is associated with suicide attempt in bipolar disorder. Acta Psychiatr. Scand. 120 (2009), 30–36.
42. Smith, K.A., Cipriani, A., Lithium and suicide in mood disorders: updated meta-review of the scientific literature. Bipolar Disord. 19 (2017), 575–586.
43. Smith, L.A., Cornelius, V.R., Azorin, J.M., Perugi, G., Vieta, E., Young, A.H., Bowden, C.L., Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis. J. Affect. Disord. 122 (2010), 1–9.
44. Song, J., Sjolander, A., Joas, E., Bergen, S.E., Runeson, B., Larsson, H., Landen, M., Lichtenstein, P., Suicidal behavior during lithium and valproate treatment: a within-individual 8-year prospective study of 50,000 patients with bipolar disorder. Am. J. Psychiatry 174 (2017), 795–802.
45. Tobias, A., Assessing the influence of a single study in meta-analysis. Stata Tech. Bull. 47 (1999), 15–17.
46. Toffol, E., Hatonen, T., Tanskanen, A., Lonnqvist, J., Wahlbeck, K., Joffe, G., Tiihonen, J., Haukka, J., Partonen, T., Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: a nationwide registry-based prospective cohort study. J. Affect. Disord. 183 (2015), 159–165.
47. Tondo, L., Baldessarini, R.J., 2018. Antisuicidal effects in mood disorders: are they unique to lithium? Pharmacopsychiatry. 51, 177–188.
48. Tondo, L., Pompili, M., Forte, A., Baldessarini, R.J., Suicide attempts in bipolar disorders: comprehensive review of 101 reports. Acta Psychiatr. Scand. 133 (2016), 174–186.
49. Tsai, C.J., Cheng, C., Chou, P.H., Lin, C.H., McInnis, M.G., Chang, C.L., Lan, T.H., The rapid suicide protection of mood stabilizers on patients with bipolar disorder: a nationwide observational cohort study in Taiwan. J. Affect. Disord. 196 (2016), 71–77.
50. Yatham, L.N., Kennedy, S.H., Parikh, S.V., Schaffer, A., Bond, D.J., Frey, B.N., Sharma, V., Goldstein, B.I., Rej, S., Beaulieu, S., Alda, M., MacQueen, G., Milev, R.V., Ravindran, A., O'Donovan, C., McIntosh, D., Lam, R.W., Vazquez, G., Kapczinski, F., McIntyre, R.S., Kozicky, J., Kanba, S., Lafer, B., Suppes, T., Calabrese, J.R., Vieta, E., Malhi, G., Post, R.M., Berk, M., Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 20 (2018), 97–170.
51. Yerevanian, B.I., Koek, R.J., Mintz, J., Bipolar pharmacotherapy and suicidal behavior. Part I: lithium, divalproex and carbamazepine. J. Affect. Disord. 103 (2007), 5–11.